O'KANE KIERAN (Chief Commercial Officer) sold 3.6% of their position (298.00 shares) of BIODESIX INC on the open market
Open‑market sale worth $2.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/20/2026ACC: 0000905148-26-000251
Officer· Chief Commercial Officer
Since Oct 2020
-298.00
Net shares
Net seller
$2.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
805.00 acquired · 1.10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+805.00
Price / share
—
Trade value
—
% of position
10.9%
1/15/2026
7.36K→8.17K
Common Stock
Direct
Shares
−298.00
Price / share
$8.15
Trade value
$2.43K
% of position
3.6%
1/16/2026
8.17K→7.87K
Total
Net shares
+507.00
Net value
-$2.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/15/2026 | M · Option Exercise | +805.00 | — | — | 10.9% | 7.36K | 8.17K |
| Common Stock Direct | 1/16/2026 | S · Sale | −298.00 | $8.15 | $2.43K | 3.6% | 8.17K | 7.87K |
| Total | +507.00 | -$2.43K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
805.00 shares
Shares
−805.00
Strike price
Held after
1.61K
Exercisable
—
1/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock805.00 shares | 1/15/2026 | M · Option Exercise | −805.00 | — | 1.61K |